Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45M Hold
6,771
0.55% 50
2026
Q1
$2.38M Hold
6,771
0.6% 45
2025
Q4
$2.22M Hold
6,771
0.57% 48
2025
Q3
$1.91M Sell
6,771
-175
-3% -$50.8K 0.51% 53
2025
Q2
$1.94M Hold
6,946
0.55% 52
2025
Q1
$2.16M Hold
6,946
0.62% 43
2024
Q4
$1.81M Buy
6,946
+25
+0.4% +$7.42K 0.52% 52
2024
Q3
$2.23M Sell
6,921
-300
-4% -$98.1K 0.56% 42
2024
Q2
$2.26M Buy
+7,221
New +$2.12M 0.53% 45

Other funds holding AMGN

Searle & Co's AMGN Position: Q2 2026 in Review

Searle & Co held its Amgen (AMGN) position steady in Q2 2026 at 6,771 shares worth $2.45M. The position accounts for 0.55% of the portfolio, ranked #50.

Searle & Co first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Searle & Co held 6,771 shares of Amgen worth $2.45M as of Q2 2026.
  • Searle & Co left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.55% of Searle & Co's portfolio in Q2 2026, its #50 holding.
  • Searle & Co first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Searle & Co's 13F filing for Q2 2026, filed 27 Jul 2026.